Royal Bank Of Canada Has Lowered Expectations for Corteva (NYSE:CTVA) Stock Price

Corteva (NYSE:CTVA) had its price objective cut by equities research analysts at Royal Bank Of Canada from $17.00 to $11.00 in a report issued on Friday, MarketBeat.com reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada‘s price target suggests a potential upside of 16.83% from the company’s previous close.

A number of other research analysts have also commented on CTVA. New Street Research set a $17.00 price objective on shares of Corteva in a research note on Monday, October 5th. The Goldman Sachs Group reiterated a “buy” rating and set a $20.00 target price on shares of Corteva in a research note on Thursday, October 8th. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. KeyCorp raised Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 price target on the stock in a report on Wednesday, October 7th. Finally, Mizuho set a $16.00 price target on Corteva in a research report on Thursday. Fifteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $52.60.

Corteva Stock Performance

NYSE:CTVA traded up $0.23 during trading hours on Friday, reaching $9.41. 28,888,260 shares of the company’s stock were exchanged, compared to its average volume of 21,957,566. The firm has a market capitalization of $6.28 billion, a price-to-earnings ratio of 4.96, a P/E/G ratio of 1.72 and a beta of 0.58. The company has a 50-day moving average of $37.22 and a 200 day moving average of $69.57. The company has a quick ratio of 1.10, a current ratio of 1.56 and a debt-to-equity ratio of 0.14. Corteva has a 1-year low of $9.01 and a 1-year high of $90.97.

Institutional Investors Weigh In On Corteva

A number of hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Corteva in the 2nd quarter valued at approximately $4,560,180,000. Wellington Management Group LLP raised its stake in shares of Corteva by 941.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after buying an additional 6,881,875 shares in the last quarter. Royal Bank of Canada raised its stake in shares of Corteva by 202.1% during the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after buying an additional 4,989,371 shares in the last quarter. Jupiter Topco LLC purchased a new position in shares of Corteva during the 2nd quarter worth approximately $544,246,000. Finally, Bank of America Corp DE acquired a new stake in shares of Corteva in the 2nd quarter valued at approximately $484,927,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Key Headlines Impacting Corteva

Investors following CTVA have been watching these headlines:

• Positive Sentiment: Corteva pointed to new products and cost-cutting efforts as supports for a potential recovery, though these measures have not offset near-term weakness. Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut
• Neutral Sentiment: Several analysts lowered price targets following the outlook reset. Citigroup and UBS kept neutral ratings, while JPMorgan maintained overweight and RBC kept outperform ratings, signaling some analysts still see potential upside from recent levels. Read More. · Read More. · Read More. · Read More.
• Negative Sentiment: Law firms announced investigations into potential securities-law violations related to company disclosures. These are allegations under investigation, not findings of wrongdoing, but may add uncertainty for investors. Law firm investigation announcement

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.